Research and Markets has announced the addition of the "Global Continuous Glucose Monitoring Systems Market Analysis and Forecast (2016-2022)" report to their offering.

The global CGM Systems market is expected to grow at a CAGR of 24.10% from 2016 to 2022 and reach a figure of $2.13 billion by 2022.

This study includes an overview and analysis of the CGM Systems market, by components end user groups, applications, and geography, allowing the research to develop a comprehensive outlook of the market.

The market report presents a detailed and analytical study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants. The type of diabetes are categorized into three major categories, viz. type 1, type 2, and gestational in the report.

All of the above mentioned report coverage parameters are discussed across different regions such as North America, Europe, Asia Pacific (APAC), and Rest of the World (ROW).

The answers to the following key questions can be found in the report:

- What are the major drivers, challenges and opportunities of the CGM Systems market and their use cases?

- How is the blood glucose monitoring device market evolving?

- What are the driving and restraining factors in the blood glucose monitoring device market?

- What are the market shares of the leading segments of the CGM Systems market in 2015?

- How will each component of the CGM Systems grow over the forecast period and how much revenue will these account for in 2022?

- How will the market shares of the leading national markets change by 2022 and which country will lead the market in 2022?

- How the industry will evolve during the period between 2016 and 2022?

- What are the key developmental strategies implemented in different applications across all regions?

- How will the key market players leverage on key developments such as mergers & acquisitions, partnerships, and product launches among others?

- Which geographical region will lead the global CGM Systems market by the end of the forecast period?

- Who are the key players in the CGM Systems market?

- What are different end user groups in this market and how are they categorized?

- What are the different applications in which CGM devices are being used?

- What are the different used case scenarios considered under different applications?

- What are the market trends and key developments in different geographical regions?

Key Topics Covered:

Executive Summary

1 The Research Scope and Methodology

2 Market Dynamics

3 Competitive Insights

4 Industry Analysis

5 The Global CGM Systems Market Analysis & Forecast

6 Company Profiles

- A. Menarini Diagnostics

- Abbott

- Arkray Inc.

- Ascensia Diabetes Care

- AstraZeneca

- Bayer Healthcare AG

- Becton Dickinson & Co.

- Dexcom, Inc.

- Echo Therapeutics

- Eli Lilly and Company

- Glucovation

- GlySens

- Insulet Corporation

- Johnson & Johnson

- Julphar Diabetes

- Medtronic Incorporation

- Nova Biomedical

- Novo Nordisk

- Omron Healthcare

- Roche

- Sanofi Pharma

- Tandem Diabetes Care, Inc.

- Ypsomed

For more information about this report visit http://www.researchandmarkets.com/research/6hxkn7/global_continuous